Australia vs Singapore: Confirmed cases of RR-/MDR-TB
Australia
29
in 2024
Singapore
23
in 2024
Australia rank
106th
Singapore rank
107th
Confirmed cases of RR-/MDR-TB over time
- Australia
- Singapore
How they compare
Australia currently reports 29 against 23 in Singapore, a difference of 6.
That makes Australia's figure about 1.3 times Singapore's.
The two have swapped places 4 times across 19 shared years of data; in 2005 it was Australia ahead.
Australia ranks 106th and Singapore ranks 107th of 195 countries.
Australia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Australia | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 24.75 | 5.5 | 19.25 | Australia |
| 2010s | 28.5 | 17 | 11.5 | Australia |
| 2020s | 26.6 | 20.6 | 6 | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher confirmed cases of rr-/mdr-tb, Australia or Singapore?
- Australia, at 29 against 23 in Singapore as of 2024.
- What is the difference in confirmed cases of rr-/mdr-tb between Australia and Singapore?
- 6, with Australia ahead.
- How many years of comparable data are there for Australia and Singapore?
- 19 years are reported by both, from 2005 to 2024.
- How do Australia and Singapore rank globally for confirmed cases of rr-/mdr-tb?
- Australia ranks 106th and Singapore ranks 107th of 195 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Confirmed cases of RR-/MDR-TB. Statizoid refreshes it automatically from the source and publishes the full history for both places.